ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SAVA Cassava Sciences Inc

19.28
-0.60 (-3.02%)
Last Updated: 12:32:39
Delayed by 15 minutes

Period:

Draw Mode:

Volume 256,347
Bid Price 19.26
Ask Price 19.30
News -
Day High 19.7382

Low
12.3202

52 Week Range

High
32.10

Day Low 19.2058
Share Name Share Symbol Market Stock Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.60 -3.02% 19.28 12:32:39
Open Price Low Price High Price Close Price Previous Close
19.72 19.2058 19.7382 19.88
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,411 256,347 US$ 19.39 US$ 4,971,617 - 12.3202 - 32.10
Last Trade Type Quantity Price Currency
12:33:00 36 US$ 19.29 USD

Cassava Sciences (SAVA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-29k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.50%

Cassava Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.3M 43.23M - 0 -97.22M -2.25 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cassava Sciences News

Date Time Source News Article
5/10/202415:02GlobeNewswire Inc.Cassava Sciences Reports Q1 2024 Financial Results and..
5/08/202410:00GlobeNewswire Inc.Cassava Sciences Announces Over $125 Million Raised from..
5/01/202408:10GlobeNewswire Inc.Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
4/15/202408:20GlobeNewswire Inc.Redemption Date Announced for Warrants
3/25/202408:13GlobeNewswire Inc.Cassava Sciences Announces Completion of an Interim Safety..
3/04/202408:15GlobeNewswire Inc.Cassava Sciences Announces Virtual Presentation at the..
2/28/202415:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202408:22Edgar (US Regulatory)Form 8-K - Current report
2/28/202408:14GlobeNewswire Inc.Cassava Sciences Reports Full-year 2023 Financial Results..
2/07/202408:20Edgar (US Regulatory)Form 8-K - Current report
2/07/202408:08GlobeNewswire Inc.No Decline in Cognition Scores in Patients with Mild..
2/01/202415:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SAVA Message Board. Create One! See More Posts on SAVA Message Board See More Message Board Posts

Historical SAVA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.0020.9218.670919.41581,6220.281.47%
1 Month22.3522.899918.670920.57575,516-3.07-13.74%
3 Months19.8926.675718.670921.71815,103-0.61-3.07%
6 Months29.4830.1318.1822.81811,677-10.20-34.60%
1 Year24.4532.1012.320221.40982,815-5.17-21.15%
3 Years78.00146.1612.320248.822,319,510-58.72-75.28%
5 Years1.18146.161.0334.142,801,74518.101,533.90%

Cassava Sciences Description

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Your Recent History

Delayed Upgrade Clock